Heparin: Past, Present, and Future
Heparin, the most widely used anticoagulant drug in the world today, remains an animal-derived product with the attendant risks of adulteration and contamination. A contamination crisis in 2007–2008 increased the impetus to provide non-animal-derived sources of heparin, produced under cGMP condition...
Main Authors: | Eziafa I. Oduah, Robert J. Linhardt, Susan T. Sharfstein |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-07-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | http://www.mdpi.com/1424-8247/9/3/38 |
Similar Items
-
Binding of hepatic lipase to heparin: identification of specific heparin-binding residues in two distinct positive charge clusters
by: Rebecca A. Sendak, et al.
Published: (2000-02-01) -
Heparin Mimetics: Their Therapeutic Potential
by: Shifaza Mohamed, et al.
Published: (2017-10-01) -
Can We Produce Heparin/Heparan Sulfate Biomimetics Using “Mother-Nature” as the Gold Standard?
by: Brooke L. Farrugia, et al.
Published: (2015-03-01) -
Soluble Heparin and Heparan Sulfate Glycosaminoglycans Interfere with Sonic Hedgehog Solubilization and Receptor Binding
by: Dominique Manikowski, et al.
Published: (2019-04-01) -
Recombinant Heparin—New Opportunities
by: Charles Alexander Glass
Published: (2018-12-01)